IP Qualifications
Qualification |
---|
Registered Australian and New Zealand Patent Attorney |
Registered Australian Trade Mark Attorney |
Academic Qualifications
Qualification | Institution | Year of Completion |
---|---|---|
Master of Industrial Property | University of Technology, Sydney | 2009 |
Doctor of Philosophy (PhD) | University of Sydney | 2004 |
Bachelor of Science (Hons I & University Medal) | The University of Sydney/Centenary Institute of Cancer Medicine and Cell Biology | 2000 |
Postdoctoral Research Experience
Position | Organisation/Institution | Date of Tenure |
---|---|---|
Postdoctoral Fellow | Institut Pasteur (France) | 2004 - 2006 |
Fellowships/Memberships/Affiliations
Organisation | Level |
---|---|
The Institute of Patent and Trade Mark Attorneys of Australia | Member |
The Intellectual Property Society of Australia and New Zealand | Member |
Selected Patent Cooperation Treaty (PCT) Specifications
PCT Publication Number | Title of Application |
---|---|
WO2019/028494 | Multiphasic Tissue Scaffold Constructs |
WO2019/000017 | Intracellular Microrna Signatures of Insulin-producing cells |
WO2018/187829 | Detection Cascades |
WO2018/107204 | Method and apparatus for producing biofuel |
WO2018/071954 | Recombinant microcystin production |
WO2018/058172 | Biooil refining methods |
WO2017/011855 | Biomarker combinations for prostate disease |
WO2017/106899 | Therapeutic methods using erythrocytes |
WO2016/074040 | Non-invasive agent applicator |
WO2016/197180 | Upgrading residues, heavy oils and plastics |
WO2016/168885 | Therapeutic antibodies and uses thereof |
WO2016/112423 | Glypican epitopes and uses thereof |
WO2016/149771 | Streptococcal vaccine |
WO2015/106311 | Cell surface prostate cancer antigen for diagnosis |
WO2014/197937 | Methods for detecting prostate cancer |
WO2013/123552 | Detection of nucleic acids |
WO2013/188912 | Target detection and signal amplification |
Selected Publications - Scientific
Scientific Publications |
---|
Potter et al. (2007), “Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study”, J. Virol., 81(24):13904-15 |
Potter et al. (2006), “Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART”, Virology, 348(1):35-46 |
Wang, Potter et al. (2005), “Rapid and sensitive detection of severe acute respiratory syndrome coronavirus by rolling circle amplification”, J. Clin. Microbiol., 43(5):2339-44 |
Seow, Broer, Broer, Bailey, Potter, et al. (2004), “Hartnup disorder is caused by mutations in the neutral amino acid transporter, SLC6A19”, Nature Genetics. 36(9):1003-7 |
Potter et al. (2004), “HIV-1 Compartmentalization in Diverse Leukocyte Populations During Antiretroviral Therapy”, J. Leuk. Biol., 76(3):562-70 |
Potter et al. (2003), “Differential cellular distribution of HIV-1 drug resistance in vivo: evidence for infection of CD8+ T cells during HAART”, Virology, 305(2):339-52 |
Potter et al. (2002), “Hartnup disorder: polymorphisms identified in the neutral amino acid transporter SLC1A5”, J. Inherit. Metab. Dis.,25(6):437-48 |
Experience and Technical Background
Experienced in the following areas of patent practice:
- Patent Drafting
- Local & Foreign Patent Prosecution
- Patent Oppositions
- Strategic Advice
- Patentability Advice
- Validity & Infringement
Primary patent practice areas by technology:
- Immunology
- Vaccines
- Molecular Biology
- Stem Cells
- Virology
- Diagnostics
Scientific/research background:
A. General technical areas:
- Immunology
- Molecular Biology
- Virology
- Genetics
B. Honours research:
- Project investigated whether candidate neutral amino acid transporter gene SLC1A5 is responsible for metabolic disorder Hartnup disease.
- Used genetic approaches (e.g. linkage analysis) and molecular biology (e.g. sequencing, mutation and expression analysis), with some cell biology.
C. PhD research:
- Investigated the distribution and mechanisms of antiretroviral drug resistance in various leukocyte populations of HIV+ patients receiving highly active antiretroviral therapy (HAART).
- Incorporated components of molecular and cellular biology, virology and immunology.
- Developed a diagnostic assay for the SARS virus using a modified form of rolling circle amplification (RCA).
D. Postdoctoral research:
- Phenotypic and functional analyses of immune activation and T lymphocyte responses in a cohort of “HIV Controllers.”
- Immunology with particular emphasis on the cell biology of the immune system HIV controllers showed a preserved CD4+ T(CM)-cell compartment with signs of potent functional activation in the CD4+ T(EM)-cell compartment, but did not show the generalized immune activation pattern associated with disease progression in HIV patients.